CCD is due to mutations in the skeletal muscle ryanodine receptor (RYR1) gene at chromosome 19q13.1, also implicated in the malignant hyperthermia susceptibility (MHS) trait, initially recognised as a familial autosomal dominant trait by Denborough and Lovell [23] in Australia. This evidence concerns the gene RYR1 and Malignant hyperthermia.